查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1532229

微針給藥系統市場：全球產業分析、規模、佔有率、成長、趨勢、預測，2024-2033

Microneedle Drug Delivery Systems Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research發布了有關全球微針給藥系統市場的詳細研究報告。本報告詳細分析了主要市場動態，包括市場驅動因素、趨勢、機會和挑戰，並提供了對市場結構的全面見解。

關鍵見解

  • 微針給藥系統市場規模（2024年）：67億美元
  • 預估市值（2033年）：108億美元
  • 全球市場成長率（2024年至2033年年複合成長率）：5.4%

微針給藥系統市場-研究範圍：

微針藥物輸送系統市場包括各種目的是使用微針透過皮膚無痛且有效地輸送藥物的技術。這個市場包括實心微針、空心微針、溶解微針等多種類型的微針裝置，它們在透皮給藥和疫苗接種方面發揮著重要作用。該市場服務於多種行業，包括藥品、化妝品和診斷，並透過零售店、醫院和診所進行分銷。消費者對微創給藥方法的興趣增加、無痛給藥意識的增強以及自我給藥趨勢的成長推動了給藥的成長。

推動市場成長的因素：

推動全球微針給藥系統市場的關鍵因素有幾個。慢性病的增加和對有效藥物輸送系統的需求推動對微針技術的需求。微針設計和材料的技術進步提高性能和可靠性，刺激市場擴張。此外，自我藥療和家庭保健的不斷成長趨勢推動對使用者友善和非侵入性給藥系統的需求。可支配收入的增加和對優質醫療保健解決方案的關注也有助於市場擴張。

市場限制因素：

儘管成長前景廣闊，但微針給藥系統市場面臨先進微針系統的高成本和原材料價格波動的挑戰。它們還受到監管障礙和持續創新以滿足不斷變化的消費者偏好的需求的影響。此外，市場受到大量本地和無組織公司的影響，這些公司提供價格較低的替代品，這可能會限制現有品牌的市場佔有率。解決這些問題並保持競爭力需要有效的供應鏈管理、有競爭力的定價以及持續的研發投資。

市場機會：

個人化醫療和藥物輸送的不斷成長趨勢為該市場帶來了巨大的機會。高效、環保的微針系統的開發是為了滿足對永續和先進醫療技術不斷成長的需求。電子商務平台的擴張為市場成長提供了新的管道，使企業能夠接觸到更多的人。不斷發展的城市化和越來越多具有健康意識的消費者推動對高品質微針系統的需求。戰略合作夥伴關係、新技術投資以及創新藥物輸送解決方案的引進對於利用新機會和維持市場領先地位非常重要。

本報告涵蓋的主要問題

  • 推動微針給藥系統市場成長的關鍵因素是什麼？
  • 哪些類型的微針和應用領域引領微針給藥系統的採用？
  • 技術進步如何影響微針給藥系統市場的競爭格局？
  • 誰是微針給藥系統市場的主要參與者？ 他們採取什麼策略來保持競爭力？
  • 全球微針給藥系統市場的新趨勢和未來前景如何？

目錄

第1章 執行摘要

第2章 市場概述

  • 市場範圍/分類
  • 市場定義/範圍/限制

第3章 市場風險與趨勢評估

  • 風險評估
    • COVID-19 危機及其對微針給藥系統市場的影響
    • 與過去的危機相比，新冠肺炎（COVID-19）影響基準
    • 對市場價值的影響（金額）
    • 主要國家的評價
    • 依主要細分市場進行評估
    • 針對供應商的行動要點和建議
  • 影響市場的主要趨勢
  • 配方和產品開發的趨勢

第4章 市場背景

  • 主要國家微針給藥系統市場
  • 微針給藥系統市場機會評估（金額）
  • 市場情境預測
  • 投資可行性分析
  • 預測因子 - 相關性和影響
  • 市場動態

第5章 關鍵成功因素

  • 製造商致力於滲透率低但成長率高的市場
  • 押注該細分市場的高增量機會
  • 同業基準

第6章 全球市場需求分析

  • 2019-2023年市場分析
  • 2024-2033年市場預測
  • 年成長趨勢分析

第7章 世界市值分析

  • 2019-2023年市場分析（金額）
  • 2024-2033年市場預測（金額）
    • 年成長趨勢分析
    • 絕對的獲利機會

第8章 依類型：世界市場分析

  • 簡介/主要發現
  • 2019-2023年市場規模分析（金額）
  • 2024-2033年市場規模分析與預測（金額）
    • 固體
    • 中空
    • 溶解
    • 塗層
    • 其他
  • 市場吸引力分析

第9章 依材料：世界市場分析

  • 簡介/主要發現
  • 2019-2023年市場規模分析（金額）
  • 2024-2033年市場規模分析與預測（金額）
    • 矽
    • 金屬
    • 聚合物
    • 其他
  • 市場吸引力分析

第10章 依應用：世界市場分析

  • 簡介/主要發現
  • 2019-2023年市場規模分析（金額）
  • 2024-2033年市場規模分析與預測（金額）
    • 皮膚科
    • 藥物輸送
    • 疼痛管理
    • 癌症治療
    • 疫苗遞送
    • 其他
  • 市場吸引力分析

第11章 依區域：市場分析

  • 簡介
  • 2019-2023年市場規模分析（金額）
  • 2024-2033年市場規模分析與預測（金額）
    • 北美
    • 拉丁美洲
    • 歐洲
    • 亞太地區
    • 中東和非洲（中東、非洲）
  • 市場吸引力分析

第12章 北美微針給藥系統市場分析

第13章 拉丁美洲微針給藥系統市場分析

第14章 歐洲微針給藥系統市場分析

第15章 亞太地區微針給藥系統市場分析

第16章 中東與非洲微針給藥系統市場分析

第17章 主要國家微針給藥系統市場分析

  • 簡介
    • 主要國家市值比例分析
    • 世界與國家成長比較
  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 德國
  • 法國
  • 義大利
  • 印度
  • 英國
  • 澳洲
  • 中國
  • 日本
  • 韓國
  • 以色列
  • 南非
  • 阿聯酋
  • 西班牙
  • 俄羅斯
  • 沙烏地阿拉伯
  • 國內競爭情勢及參與者集中度

第18章 市場結構分析

  • 依公司層級的市場分析
  • 市場集中度
  • 主要公司市佔率分析
  • 市場現況分析

第19章 競爭分析

  • 競爭儀表板
  • 競爭基準
  • 競爭詳情
    • Raphas Co. Ltd.
    • Becton Dickinson and Company
    • NanoPass Technologies Limited
    • 3M
    • Zosano Pharma Corporation
    • Corium International Inc.
    • Valeritas Inc.
    • Nitto Denko Corporation
    • Microdermics Inc.
    • TheraJect Inc.
    • Vaxxas Pty Ltd.
    • Endoderma Ltd.
    • QuadMedicine
    • SNvia Co. Ltd.
    • Small Lab

第20章 使用的先決條件與縮寫

第21章 研究方法

簡介目錄
Product Code: PMRREP33284

Persistence Market Research has recently published a detailed report on the global Microneedle Drug Delivery Systems market. This report offers an in-depth analysis of critical market dynamics, including drivers, trends, opportunities, and challenges, providing comprehensive insights into the market structure.

Key Insights:

  • Microneedle Drug Delivery Systems Market Size (2024E): USD 6.7 Bn
  • Projected Market Value (2033F): USD 10.8 Bn
  • Global Market Growth Rate (CAGR 2024 to 2033): 5.4%

Microneedle Drug Delivery Systems Market - Report Scope:

The Microneedle Drug Delivery Systems market encompasses a range of technologies designed to deliver drugs painlessly and effectively through the skin using microneedles. This market includes various types of microneedle devices such as solid microneedles, hollow microneedles, and dissolving microneedles, which are crucial for transdermal drug delivery and vaccination. The market serves different segments, including pharmaceuticals, cosmetics, and diagnostics, distributed through retail, hospitals, and clinics. Growth is driven by increasing consumer interest in minimally invasive drug delivery methods, rising awareness about pain-free administration, and the growing trend of self-administration of drugs.

Market Growth Drivers:

Several key factors drive the global Microneedle Drug Delivery Systems market. The rising prevalence of chronic diseases and the need for effective drug delivery systems boost demand for microneedle technologies. Technological advancements in microneedle design and materials enhance performance and reliability, fueling market expansion. Additionally, the growing trend of self-medication and home healthcare drives the demand for user-friendly and non-invasive drug delivery systems. Increased disposable income and a focus on premium healthcare solutions also contribute to market growth.

Market Restraints:

Despite promising growth prospects, the Microneedle Drug Delivery Systems market faces challenges related to the high cost of advanced microneedle systems and fluctuating raw material prices. The market is also impacted by regulatory hurdles and the need for continuous innovation to meet evolving consumer preferences. Furthermore, the market is influenced by the presence of numerous local and unorganized players offering lower-cost alternatives, which can limit market share for established brands. Effective supply chain management, competitive pricing, and ongoing investment in research and development are necessary to address these issues and maintain a competitive edge.

Market Opportunities:

The market presents significant opportunities driven by the rising trend of personalized medicine and targeted drug delivery. The development of high-efficiency and eco-friendly microneedle systems caters to the growing demand for sustainable and advanced healthcare technologies. The expansion of e-commerce platforms provides new channels for market growth, allowing companies to reach a broader audience. Increasing urbanization and the rising number of health-conscious consumers drive the demand for high-quality microneedle systems. Strategic partnerships, investments in new technologies, and the introduction of innovative drug delivery solutions are essential for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Microneedle Drug Delivery Systems market globally?
  • Which microneedle types and application areas are leading the adoption of microneedle drug delivery systems?
  • How are technological advancements influencing the competitive landscape of the Microneedle Drug Delivery Systems market?
  • Who are the key players in the Microneedle Drug Delivery Systems market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global Microneedle Drug Delivery Systems market?

Competitive Intelligence and Business Strategy:

Leading players in the global Microneedle Drug Delivery Systems market, including 3M, Becton Dickinson and Company, and Zosano Pharma Corporation, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced microneedle technologies, such as dissolvable microneedles and integrated microneedle patches. Collaborations with pharmaceutical companies, research institutions, and online platforms facilitate market access and promote new product adoption. Emphasis on sustainable manufacturing processes, high-performance materials, and comprehensive marketing strategies fosters market growth and enhances brand loyalty in the evolving Microneedle Drug Delivery Systems landscape.

Key Companies Profiled:

  • Raphas Co. Ltd.
  • Becton Dickinson and Company
  • NanoPass Technologies Limited
  • 3M
  • Zosano Pharma Corporation
  • Corium International Inc.
  • Valeritas Inc.
  • Nitto Denko Corporation
  • Microdermics Inc.
  • TheraJect Inc.
  • Vaxxas Pty Ltd.
  • Endoderma Ltd.
  • QuadMedicine
  • SNvia Co. Ltd.
  • Small Lab

Microneedle Drug Delivery Systems Market Industry Segmentation

By Type

  • Solid
  • Hollow
  • Dissolving
  • Coated
  • Other Types

By Material

  • Silicon
  • Metal
  • Polymer
  • Other Materials

By Application

  • Dermatology
  • Drug Delivery
  • Pain Management
  • Cancer Therapy
  • Vaccine Delivery
  • Other Applications

By Region

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Summary of Statistics
  • 1.3. Key Market Characteristics & Attributes
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

  • 3.1. Risk Assessment
    • 3.1.1. COVID-19 Crisis and Impact on Microneedle Drug Delivery Systems Market
    • 3.1.2. COVID-19 Impact Benchmark with Previous Crisis
    • 3.1.3. Impact on Market Value (US$ Bn)
    • 3.1.4. Assessment by Key Countries
    • 3.1.5. Assessment by Key Market Segments
    • 3.1.6. Action Points and Recommendation for Suppliers
  • 3.2. Key Trends Impacting the Market
  • 3.3. Formulation and Product Development Trends

4. Market Background

  • 4.1. Microneedle Drug Delivery Systems Market, by Key Countries
  • 4.2. Microneedle Drug Delivery Systems Market Opportunity Assessment (US$ Bn)
    • 4.2.1. Total Available Market
    • 4.2.2. Serviceable Addressable Market
    • 4.2.3. Serviceable Obtainable Market
  • 4.3. Market Scenario Forecast
    • 4.3.1. Demand in optimistic Scenario
    • 4.3.2. Demand in Likely Scenario
    • 4.3.3. Demand in Conservative Scenario
  • 4.4. Investment Feasibility Analysis
    • 4.4.1. Investment in Established Markets
      • 4.4.1.1. In Short Term
      • 4.4.1.2. In Long Term
    • 4.4.2. Investment in Emerging Markets
      • 4.4.2.1. In Short Term
      • 4.4.2.2. In Long Term
  • 4.5. Forecast Factors - Relevance & Impact
    • 4.5.1. Top Companies Historical Growth
    • 4.5.2. Growth in Automation, By Country
    • 4.5.3. Microneedle Drug Delivery Systems Markets Adoption Rate, By Country
  • 4.6. Market Dynamics
    • 4.6.1. Market Driving Factors and Impact Assessment
    • 4.6.2. Prominent Market Challenges and Impact Assessment
    • 4.6.3. Microneedle Drug Delivery Systems Markets Market Opportunities
    • 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

  • 5.1. Manufacturers' Focus on Low Penetration High Growth Markets
  • 5.2. Banking on with Segments High Incremental Opportunity
  • 5.3. Peer Benchmarking

6. Global Microneedle Drug Delivery Systems Market Demand Analysis 2019-2023 and Forecast, 2024-2033

  • 6.1. Historical Market Analysis, 2019-2023
  • 6.2. Current and Future Market Projections, 2024-2033
  • 6.3. Y-o-Y Growth Trend Analysis

7. Global Microneedle Drug Delivery Systems Market Value Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033, By Type

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Bn) Analysis By Type, 2019-2023
  • 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Type, 2024-2033
    • 8.3.1. Solid
    • 8.3.2. Hollow
    • 8.3.3. Dissolving
    • 8.3.4. Coated
    • 8.3.5. Other Types
  • 8.4. Market Attractiveness Analysis By Microneedle Drug Delivery Systems

9. Global Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033, By Material

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn) Analysis By Material, 2019-2023
  • 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Material, 2024-2033
    • 9.3.1. Silicon
    • 9.3.2. Metal
    • 9.3.3. Polymer
    • 9.3.4. Other Materiales
  • 9.4. Market Attractiveness Analysis By Application

10. Global Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033, By Application

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2024-2033
    • 10.3.1. Dermatology
    • 10.3.2. Drug Delivery
    • 10.3.3. Pain Management
    • 10.3.4. Cancer Therapy
    • 10.3.5. Vaccine Delivery
    • 10.3.6. Other Applications
  • 10.4. Market Attractiveness Analysis By Application

11. Global Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
  • 11.3. Current Market Size (US$ Bn) & Analysis and Forecast By Region, 2024-2033
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. Asia Pacific
    • 11.3.5. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis By Region

12. North America Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Pricing Analysis
  • 12.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
    • 12.4.1. By Country
      • 12.4.1.1. U.S.
      • 12.4.1.2. Canada
    • 12.4.2. By Type
    • 12.4.3. By Application
    • 12.4.4. By Application
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Country
    • 12.5.2. By Material
    • 12.5.3. By Application
    • 12.5.4. By Application

13. Latin America Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Pricing Analysis
  • 13.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
    • 13.4.1. By Country
      • 13.4.1.1. Brazil
      • 13.4.1.2. Mexico
      • 13.4.1.3. Rest of Latin America
    • 13.4.2. By Type
    • 13.4.3. By Application
    • 13.4.4. By Application
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Country
    • 13.5.2. By Material
    • 13.5.3. By Application
    • 13.5.4. By Application

14. Europe Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
    • 14.4.1. By Country
      • 14.4.1.1. Germany
      • 14.4.1.2. France
      • 14.4.1.3. U.K.
      • 14.4.1.4. Italy
      • 14.4.1.5. Spain
      • 14.4.1.6. Russia
      • 14.4.1.7. Rest of Europe
    • 14.4.2. By Type
    • 14.4.3. By Application
    • 14.4.4. By Application
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Material
    • 14.5.3. By Application
    • 14.5.4. By Application

15. Asia Pacific Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
    • 15.4.1. By Country
      • 15.4.1.1. China
      • 15.4.1.2. Japan
      • 15.4.1.3. South Korea
      • 15.4.1.4. India
      • 15.4.1.5. Australia
      • 15.4.1.6. Rest of Asia Pacific
    • 15.4.2. By Type
    • 15.4.3. By Application
    • 15.4.4. By Application
  • 15.5. Market Attractiveness Analysis
    • 15.5.1. By Country
    • 15.5.2. By Material
    • 15.5.3. By Application
    • 15.5.4. By Application

16. Middle East and Africa Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Pricing Analysis
  • 16.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
    • 16.4.1. By Country
      • 16.4.1.1. Saudi Arabia
      • 16.4.1.2. South Africa
      • 16.4.1.3. Israel
      • 16.4.1.4. UAE
      • 16.4.1.5. Rest of Middle East and Africa
    • 16.4.2. By Type
    • 16.4.3. By Application
    • 16.4.4. By Application
  • 16.5. Market Attractiveness Analysis
    • 16.5.1. By Country
    • 16.5.2. By Material
    • 16.5.3. By Application
    • 16.5.4. By Application

17. Key Countries Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
    • 17.1.1. Market Value Proportion Analysis, By Key Countries
    • 17.1.2. Global Vs. Country Growth Comparison
  • 17.2. US Microneedle Drug Delivery Systems Market Analysis
    • 17.2.1. Value Proportion Analysis by Market Taxonomy
    • 17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.2.2.1. By Type
      • 17.2.2.2. By Application
      • 17.2.2.3. By Application
  • 17.3. Canada Microneedle Drug Delivery Systems Market Analysis
    • 17.3.1. Value Proportion Analysis by Market Taxonomy
    • 17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.3.2.1. By Material
      • 17.3.2.2. By Application
      • 17.3.2.3. By Application
  • 17.4. Mexico Microneedle Drug Delivery Systems Market Analysis
    • 17.4.1. Value Proportion Analysis by Market Taxonomy
    • 17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.4.2.1. By Type
      • 17.4.2.2. By Application
      • 17.4.2.3. By Application
  • 17.5. Brazil Microneedle Drug Delivery Systems Market Analysis
    • 17.5.1. Value Proportion Analysis by Market Taxonomy
    • 17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.5.2.1. By Material
      • 17.5.2.2. By Application
      • 17.5.2.3. By Application
  • 17.6. Germany Microneedle Drug Delivery Systems Market Analysis
    • 17.6.1. Value Proportion Analysis by Market Taxonomy
    • 17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.6.2.1. By Type
      • 17.6.2.2. By Application
      • 17.6.2.3. By Application
  • 17.7. France Microneedle Drug Delivery Systems Market Analysis
    • 17.7.1. Value Proportion Analysis by Market Taxonomy
    • 17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.7.2.1. By Type
      • 17.7.2.2. By Application
      • 17.7.2.3. By Application
  • 17.8. Italy Microneedle Drug Delivery Systems Market Analysis
    • 17.8.1. Value Proportion Analysis by Market Taxonomy
    • 17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.8.2.1. By Type
      • 17.8.2.2. By Application
      • 17.8.2.3. By Application
  • 17.9. India Microneedle Drug Delivery Systems Market Analysis
    • 17.9.1. Value Proportion Analysis by Market Taxonomy
    • 17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.9.2.1. By Type
      • 17.9.2.2. By Application
      • 17.9.2.3. By Application
  • 17.10. UK Microneedle Drug Delivery Systems Market Analysis
    • 17.10.1. Value Proportion Analysis by Market Taxonomy
    • 17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.10.2.1. By Material
      • 17.10.2.2. By Application
      • 17.10.2.3. By Application
  • 17.11. Australia Microneedle Drug Delivery Systems Market Analysis
    • 17.11.1. Value Proportion Analysis by Market Taxonomy
    • 17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.11.2.1. By Type
      • 17.11.2.2. By Application
      • 17.11.2.3. By Application
  • 17.12. China Microneedle Drug Delivery Systems Market Analysis
    • 17.12.1. Value Proportion Analysis by Market Taxonomy
    • 17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.12.2.1. By Type
      • 17.12.2.2. By Application
      • 17.12.2.3. By Application
  • 17.13. Japan Microneedle Drug Delivery Systems Market Analysis
    • 17.13.1. Value Proportion Analysis by Market Taxonomy
    • 17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.13.2.1. By Type
      • 17.13.2.2. By Application
      • 17.13.2.3. By Application
  • 17.14. South Korea Microneedle Drug Delivery Systems Market Analysis
    • 17.14.1. Value Proportion Analysis by Market Taxonomy
    • 17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.14.2.1. By Type
      • 17.14.2.2. By Application
      • 17.14.2.3. By Application
  • 17.15. Israel Microneedle Drug Delivery Systems Market Analysis
    • 17.15.1. Value Proportion Analysis by Market Taxonomy
    • 17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.15.2.1. By Type
      • 17.15.2.2. By Application
      • 17.15.2.3. By Application
  • 17.16. South Africa Microneedle Drug Delivery Systems Market Analysis
    • 17.16.1. Value Proportion Analysis by Market Taxonomy
    • 17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.16.2.1. By Type
      • 17.16.2.2. By Application
      • 17.16.2.3. By Application
  • 17.17. UAE Microneedle Drug Delivery Systems Market Analysis
    • 17.17.1. Value Proportion Analysis by Market Taxonomy
    • 17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.17.2.1. By Type
      • 17.17.2.2. By Application
      • 17.17.2.3. By Application
  • 17.18. Spain Microneedle Drug Delivery Systems Market Analysis
    • 17.18.1. Value Proportion Analysis by Market Taxonomy
    • 17.18.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.18.2.1. By Type
      • 17.18.2.2. By Application
      • 17.18.2.3. By Application
  • 17.19. Russia Microneedle Drug Delivery Systems Market Analysis
    • 17.19.1. Value Proportion Analysis by Market Taxonomy
    • 17.19.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.19.2.1. By Type
      • 17.19.2.2. By Application
      • 17.19.2.3. By Application
  • 17.20. Saudi Arabia Microneedle Drug Delivery Systems Market Analysis
    • 17.20.1. Value Proportion Analysis by Market Taxonomy
    • 17.20.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.20.2.1. By Type
      • 17.20.2.2. By Application
      • 17.20.2.3. By Application
  • 17.21. Competition Landscape and Player Concentration in the Country

18. Market Structure Analysis

  • 18.1. Market Analysis by Tier of Companies
  • 18.2. Market Concentration
  • 18.3. Market Share Analysis of Top Players
  • 18.4. Market Presence Analysis
    • 18.4.1. By Regional footprint of Players
    • 18.4.2. Product footprint by Players

19. Competition Analysis

  • 19.1. Competition Dashboard
  • 19.2. Competition Benchmarking
  • 19.3. Competition Deep Dive
    • 19.3.1. Raphas Co. Ltd.
      • 19.3.1.1. Overview
      • 19.3.1.2. Product Portfolio
      • 19.3.1.3. Sales Footprint
      • 19.3.1.4. Strategy Overview
    • 19.3.2. Becton Dickinson and Company
      • 19.3.2.1. Overview
      • 19.3.2.2. Product Portfolio
      • 19.3.2.3. Sales Footprint
      • 19.3.2.4. Strategy Overview
    • 19.3.3. NanoPass Technologies Limited
      • 19.3.3.1. Overview
      • 19.3.3.2. Product Portfolio
      • 19.3.3.3. Sales Footprint
      • 19.3.3.4. Strategy Overview
    • 19.3.4. 3M
      • 19.3.4.1. Overview
      • 19.3.4.2. Product Portfolio
      • 19.3.4.3. Sales Footprint
      • 19.3.4.4. Strategy Overview
    • 19.3.5. Zosano Pharma Corporation
      • 19.3.5.1. Overview
      • 19.3.5.2. Product Portfolio
      • 19.3.5.3. Sales Footprint
      • 19.3.5.4. Strategy Overview
    • 19.3.6. Corium International Inc.
      • 19.3.6.1. Overview
      • 19.3.6.2. Product Portfolio
      • 19.3.6.3. Sales Footprint
      • 19.3.6.4. Strategy Overview
    • 19.3.7. Valeritas Inc.
      • 19.3.7.1. Overview
      • 19.3.7.2. Product Portfolio
      • 19.3.7.3. Sales Footprint
      • 19.3.7.4. Strategy Overview
    • 19.3.8. Nitto Denko Corporation
      • 19.3.8.1. Overview
      • 19.3.8.2. Product Portfolio
      • 19.3.8.3. Sales Footprint
      • 19.3.8.4. Strategy Overview
    • 19.3.9. Microdermics Inc.
      • 19.3.9.1. Overview
      • 19.3.9.2. Product Portfolio
      • 19.3.9.3. Sales Footprint
      • 19.3.9.4. Strategy Overview
    • 19.3.10. TheraJect Inc.
      • 19.3.10.1. Overview
      • 19.3.10.2. Product Portfolio
      • 19.3.10.3. Sales Footprint
      • 19.3.10.4. Strategy Overview
    • 19.3.11. Vaxxas Pty Ltd.
      • 19.3.11.1. Overview
      • 19.3.11.2. Product Portfolio
      • 19.3.11.3. Sales Footprint
      • 19.3.11.4. Strategy Overview
    • 19.3.12. Endoderma Ltd.
      • 19.3.12.1. Overview
      • 19.3.12.2. Product Portfolio
      • 19.3.12.3. Sales Footprint
      • 19.3.12.4. Strategy Overview
    • 19.3.13. QuadMedicine
      • 19.3.13.1. Overview
      • 19.3.13.2. Product Portfolio
      • 19.3.13.3. Sales Footprint
      • 19.3.13.4. Strategy Overview
    • 19.3.14. SNvia Co. Ltd.
      • 19.3.14.1. Overview
      • 19.3.14.2. Product Portfolio
      • 19.3.14.3. Sales Footprint
      • 19.3.14.4. Strategy Overview
    • 19.3.15. Small Lab
      • 19.3.15.1. Overview
      • 19.3.15.2. Product Portfolio
      • 19.3.15.3. Sales Footprint
      • 19.3.15.4. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology